Venlafaxine: OOS result for Spheroids Dissolution Rate Profile (DRP)
Issued September 21, 2022
Issue
Out of specification result for Spheroids Dissolution Rate Profile (DRP)
Hazard description
Product quality
What to do
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Product
Product name
TARO-VENLAFAXINE XR
Companies
Recalling firm
Sun Pharma Canada Inc. (formerly Ranbaxy Pharmaceuticals Canada Inc.) 126 East Drive, Brampton, ON, L6T 1C1
Reference
ID
RA-64571
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker